KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Treasury Shares (2016 - 2025)

Medpace Holdings (MEDP) has disclosed Treasury Shares for 9 consecutive years, with $12.2 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Treasury Shares changed 0.0% year-over-year to $12.2 million, compared with a TTM value of $12.2 million through Sep 2025, changed 0.0%, and an annual FY2024 reading of $12.2 million, down 0.71% over the prior year.
  • Treasury Shares was $69623.0 for Q4 2025 at Medpace Holdings, down from $70073.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $602187.0 in Q4 2021 and bottomed at $69623.0 in Q4 2025.
  • Average Treasury Shares over 5 years is $154406.7, with a median of $70573.0 recorded in 2023.
  • The sharpest move saw Treasury Shares soared 155.34% in 2022, then decreased 13.49% in 2023.
  • Year by year, Treasury Shares stood at $5.4 million in 2021, then surged by 130.27% to $12.5 million in 2022, then decreased by 1.4% to $12.3 million in 2023, then fell by 0.71% to $12.2 million in 2024, then changed by 0.0% to $12.2 million in 2025.
  • Business Quant data shows Treasury Shares for MEDP at $12.2 million in Q3 2025, $12.2 million in Q2 2025, and $12.2 million in Q1 2025.